| Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro TL Toft-Bertelsen, MG Jeppesen, E Tzortzini, K Xue, K Giller, S Becker, ... Communications biology 4 (1), 1347, 2021 | 54 | 2021 |
| Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist Using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy … P Lagarias, K Barkan, E Tzortzini, M Stampelou, E Vrontaki, G Ladds, ... Journal of chemical information and modeling 59 (12), 5183-5197, 2019 | 26 | 2019 |
| Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure− Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations M Stampelou, A Suchankova, E Tzortzini, L Dhingra, K Barkan, ... Journal of Medicinal Chemistry 65 (19), 13305-13327, 2022 | 11 | 2022 |
| Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro TL Toft-Bertelsen, MG Jeppesen, E Tzortzini, K Xue, K Giller, S Becker, ... Communications Biology 4, 1402, 2021 | 10 | 2021 |
| Investigation of tumor cells and receptor-ligand simulation models for the development of PET imaging probes targeting PSMA and GRPR and a possible crosstalk between the two … C Liolios, C Patsis, G Lambrinidis, E Tzortzini, M Roscher, U Bauder-Wust, ... Molecular pharmaceutics 19 (7), 2231-2247, 2022 | 9 | 2022 |
| Comparative Study of Receptor-, Receptor State-, and Membrane-Dependent Cholesterol Binding Sites in A2A and A1 Adenosine Receptors Using Coarse … E Tzortzini, RA Corey, A Kolocouris Journal of Chemical Information and Modeling 63 (3), 928-949, 2023 | 7 | 2023 |
| Molecular Biophysics of Class A G Protein Coupled Receptors–Lipids Interactome at a Glance—Highlights from the A2A Adenosine Receptor E Tzortzini, A Kolocouris Biomolecules 13 (6), 957, 2023 | 6 | 2023 |
| Novel Pyrazolo [3, 4-c] Pyridine Antagonists with Nanomolar Affinity for A1/A3 Adenosine Receptors: Binding Kinetics and Exploration of Their Binding Profile Using Mutagenesis … M Stampelou, A Suchankova, E Tzortzini, L Dhingra, K Barkan, ... | 2 | 2021 |
| Comparative Study of State-Dependent Cholesterol Binding Sites in Adenosine A2A and A1 Receptors Using Coarse-Grained Molecular Dynamics Simulations in … E Tzortzini, RA Corey, A Kolocouris bioRxiv, 2022.09. 28.509875, 2022 | 1 | 2022 |
| BPS2025-Molecular pharmacology of human P2X7 receptor ligands visualized by cryo-EM AC Oken, AL Turcu, K Georgiou, E Tzortzini, J Nagel, YC Kim, ... Biophysical Journal 124 (3), 282a, 2025 | | 2025 |
| UB-MBX-46 is a potent and selective antagonist of the human P2X7 receptor developed by structure-based drug design AC Oken, AL Turcu, E Tzortzini, K Georgiou, J Nagel, M Barniol-Xicota, ... bioRxiv, 2025.02. 12.637899, 2025 | | 2025 |
| Study of state-dependent allosteric cholesterol binding sites in adenosine A2A, A1 receptors using coarse-grained molecular dynamics simulations in plasma mimetic membranes E Tzortzini Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Σχολή Επιστημών Υγείας …, 2023 | | 2023 |
| Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro (vol 4, 1347, 2021) TL Toft-Bertelsen, MG Jeppesen, E Tzortzini, K Xue, K Giller, S Becker, ... COMMUNICATIONS BIOLOGY 4 (1), 2021 | | 2021 |
| Correction to Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free … P Lagarias, K Barkan, E Tzortzini, M Stampelou, E Vrontaki, G Ladds, ... Journal of Chemical Information and Modeling 60 (4), 2405-2406, 2020 | | 2020 |
| Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist using Molecular Dynamics Simulations, Binding Free Energy Calculations and Mutagenesis P Lagarias, K Barkan, E Tzortzini, E Vrontaki, M Stampelou, G Ladds, ... | | 2019 |
